.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Healthtrust
Covington
Teva
QuintilesIMS
Queensland Health
US Army
Johnson and Johnson
Moodys

Generated: February 17, 2018

DrugPatentWatch Database Preview

Drug Master Files for: doxorubicin

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
2098AII4/27/1973PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INCDOXORUBICIN HYDROCHLORIDE
13136IV10/9/1998PHARMACIA AND UPJOHNTOXICOLOGY INFORMATION FOR IODODOXORUBICIN HCL
13209AII4/30/1998MEIJI SEIKA PHARMA CO LTDDOXORUBICIN HYDROCHLORIDE DRUG SUBSTANCE
13211AII4/30/1998MICROBIOPHARM JAPAN CO LTDDOXORUBICIN HYDROCHLORIDE
13726AII9/1/1998TEVA PHARMACEUTICAL INDUSTRIES LTDDOXORUBICIN HYDROCHLORIDE
13773AII9/1/1998ZHEJIANG HISUN PHARMACEUTICAL CO LTDDOXORUBICIN HYDROCHLORIDE USP
13825III11/9/1998PHARMACIA AND UPJOHN SPAIODODOXORUBICIN HCL BULK DRUG SUBSTANCE
13889III12/7/1998PHARMACIA AND UPJOHN SPAIODODOXORUBICIN HCL FOR INJECTION
15514III7/3/2001PHARMACIA AND UPJOHNDOXORUBICIN HCL
16178AII10/9/2002SYNBIAS PHARMA LTDDOXORUBICIN HYDROCHLORIDE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
Argus Health
AstraZeneca
Novartis
Cerilliant
Mallinckrodt
Colorcon
Accenture
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot